CONFERENCE UPDATES: ESMO 2021

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent or metastatic cervical cancer: Phase 3 KEYNOTE-826 study

ONCOLOGY OBSTETRICS & GYNECOLOGY
04 Oct 2021

Get access to our exclusive articles.